<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170101031697N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-01-07</date_registration>
      <primary_sponsor>Bandare-abbas University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of articaine infiltrated anesthesia with lidocaine block anesthesia in the treatment of mandibular second molar palpotomy</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the anesthetic efficacy of Articaine infiltration versus lidocaine inferior alveolar nerve block in pulp therapy of lower second primary molars</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-12-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>76</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/53246</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Crossover, Purpose: Treatment, Randomization description: In this study, randomization of participants as an individual unit and simple randomization, which will be divided into two equal groups based on the random division command in SPSS software, Blinding description: Participant: The participant's blindness is such that before injecting anesthesia, the person is asked to open his mouth, at which time the injector waits for a minute and then injects. This causes the patient not to notice the injection.
Impact Assessor: The outcome assessor will not be aware of the type of injection when evaluating the patient.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Local anesthesia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: the first session of lidocaine infraalveolar nerve block injection and the second session of articaine infiltration injection. In this group, in order to pulpotomy of second primary mandibular molar in one session, after preparing radiography and performing the initial steps for treatment, infra alveolar nerve block injection using carpol lidocaine 2% with epinephrine 1: 100000, for a child at one minute will be done. After the appropriate time (10 minutes) and ensuring complete anesthesia by using the lip anesthesia index, we begin the process of removing the caries and preparing the access cavity, and the child's reaction will be measured at the moment of pulp exposure. Before the test, we explain the VAS (Visual Analogue Scale) diagram and how to show the amount of discomfort on it to the child and immediately ask the child during the cutting of the cavity in the dentin or in cases of pulp treatment at the moment of pulp exposure to mark the appropriate face on the VAS chart, depending on the amount of pain or discomfort. The same child will be treated for the pulpotomy of second primary mandibular molar in opposite side in the next session, one week after the first session. After preparing the radiography and performing the initial steps for treatment, infiltration injection in the vicinity of the target tooth using carpool articaine 4% with epinephrine 1: 100000, will be performed for the child in one minute. After the appropriate time (10 minutes) and ensuring complete anesthesia by using the lip anesthesia index, we begin the process of caries removal and preparation of the access cavity, and the child's reaction will be measured at the moment of pulp exposure. Explain the Visual Analogue Scale and how to display the amount of discomfort on it to the child and immediately when cutting the cavity in the dentin or in cases of need for pulp treatment at the moment of pulp exposure, we ask the child to mark the appropriate face on the VAS chart, depending on the amount of pain or discomfort. Intervention 2: Intervention group: The first session of articaine infiltration injection and the second session of lidocaine infra alveolar nerve block injection. In this group, in order to pulpotomy of second primary mandibular molar in one session, after preparing radiography and performing the initial steps for treatment, infiltration injection in the vicinity of the target tooth using 4% carpool articaine with 1: 100000 epinephrine, for the child It will be done in one minute. After the appropriate time (10 minutes) and ensuring complete anesthesia by using the lip anesthesia index, we begin the process of removing the caries and preparing the access cavity, and the child's reaction will be measured at the moment of pulp exposure. Before the test, we explain the VAS (Visual Analogue Scale) diagram and how to show the amount of discomfort on it to the child and immediately ask the child during the cutting of the cavity in the dentin or in cases of pulp treatment at the moment of pulp exposure to mark the appropriate face on the VAS chart, depending on the amount of pain or discomfort, and the same child will be treated for the opposite side of the mandible in the next session, one week after the first session. After preparing radiography and performing the initial steps for treatment, infra alveolar nerve block injection using carpol lidocaine 2% with epinephrine 1: 100000, for a child at one minute will be done. After the appropriate time (10 minutes) and ensuring complete anesthesia by using the lip anesthesia index, we begin the process of removing the caries and preparing the access cavity, and the child's reaction will be measured at the moment of pulp exposure. Before the test, we explain the VAS (Visual Analogue Scale) diagram and how to show the amount of discomfort on it to the child and immediately ask the child during the cutting of the cavity in the dentin or in cases of pulp treatment at the moment of pulp exposure to mark the appropriate face on the VAS chart, depending on the amount of pain or discomfort.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The information obtained from this study can be shared without the ability to identify participants.

When:
From October 2021

To whom:
Researchers and referees

Conditions:
Obtaining a written permit and mentioning the name in the sources and references

Where to obtain:
Sara Bakhshaei
saraesmaili43@gmail.com

How to obtain:
The request must first be emailed and answered after review and approval.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sara Esmaeili</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dental Clinic of Bandar Abbas School of Dentistry, Shahid Naser St, Imam Khomeini Blvd</address>
        <city>Bandar Abbas</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7919915519</zip>
        <telephone>+98 76 3334 5009</telephone>
        <email>saraesmaili43@gmail.com</email>
        <affiliation>Bandare-abbas University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sara Esmaeili</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dental Clinic of Bandar Abbas School of Dentistry, Shahid Naser St, Imam Khomeini Blvd</address>
        <city>Bandar Abbas</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7919915519</zip>
        <telephone>+98 76 3334 5009</telephone>
        <email>saraesmaili43@gmail.com</email>
        <affiliation>Bandare-abbas University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Healthy children four to ten years old who need treatment for the pulp molars of the mandible on both sides.</inclusion_criteria>
      <agemin>4 years</agemin>
      <agemax>10 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Children who have any sores or mucosal lesions during treatment sessions in the buccal vestibule.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Y48.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Local anaesthetics</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: the first session of lidocaine infraalveolar nerve block injection and the second session of articaine infiltration injection. In this group, in order to pulpotomy of second primary mandibular molar in one session, after preparing radiography and performing the initial steps for treatment, infra alveolar nerve block injection using carpol lidocaine 2% with epinephrine 1: 100000, for a child at one minute will be done. After the appropriate time (10 minutes) and ensuring complete anesthesia by using the lip anesthesia index, we begin the process of removing the caries and preparing the access cavity, and the child's reaction will be measured at the moment of pulp exposure. Before the test, we explain the VAS (Visual Analogue Scale) diagram and how to show the amount of discomfort on it to the child and immediately ask the child during the cutting of the cavity in the dentin or in cases of pulp treatment at the moment of pulp exposure to mark the appropriate face on the VAS chart, depending on the amount of pain or discomfort. The same child will be treated for the pulpotomy of second primary mandibular molar in opposite side in the next session, one week after the first session. After preparing the radiography and performing the initial steps for treatment, infiltration injection in the vicinity of the target tooth using carpool articaine 4% with epinephrine 1: 100000, will be performed for the child in one minute. After the appropriate time (10 minutes) and ensuring complete anesthesia by using the lip anesthesia index, we begin the process of caries removal and preparation of the access cavity, and the child's reaction will be measured at the moment of pulp exposure. Explain the Visual Analogue Scale and how to display the amount of discomfort on it to the child and immediately when cutting the cavity in the dentin or in cases of need for pulp treatment at the moment of pulp exposure, we ask the child to mark the appropriate face on the VAS chart, depending on the amount of pain or discomfort.</i_keyword>
      <i_keyword>Intervention group: The first session of articaine infiltration injection and the second session of lidocaine infra alveolar nerve block injection. In this group, in order to pulpotomy of second primary mandibular molar in one session, after preparing radiography and performing the initial steps for treatment, infiltration injection in the vicinity of the target tooth using 4% carpool articaine with 1: 100000 epinephrine, for the child It will be done in one minute. After the appropriate time (10 minutes) and ensuring complete anesthesia by using the lip anesthesia index, we begin the process of removing the caries and preparing the access cavity, and the child's reaction will be measured at the moment of pulp exposure. Before the test, we explain the VAS (Visual Analogue Scale) diagram and how to show the amount of discomfort on it to the child and immediately ask the child during the cutting of the cavity in the dentin or in cases of pulp treatment at the moment of pulp exposure to mark the appropriate face on the VAS chart, depending on the amount of pain or discomfort, and the same child will be treated for the opposite side of the mandible in the next session, one week after the first session. After preparing radiography and performing the initial steps for treatment, infra alveolar nerve block injection using carpol lidocaine 2% with epinephrine 1: 100000, for a child at one minute will be done. After the appropriate time (10 minutes) and ensuring complete anesthesia by using the lip anesthesia index, we begin the process of removing the caries and preparing the access cavity, and the child's reaction will be measured at the moment of pulp exposure. Before the test, we explain the VAS (Visual Analogue Scale) diagram and how to show the amount of discomfort on it to the child and immediately ask the child during the cutting of the cavity in the dentin or in cases of pulp treatment at the moment of pulp exposure to mark the appropriate face on the VAS chart, depending on the amount of pain or discomfort.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain when exposing the pulp. Timepoint: When exposing the pulp. Method of measurement: Using the Visual Analogue Scale chart.</prim_outcome>
      <prim_outcome>Pain during injection start. Timepoint: During injection start. Method of measurement: Using the Visual Analogue Scale chart.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Bandare-abbas University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-12-23</approval_date>
        <contact_name>Ethics Committee of Bandar Abbas University of Medical Sciences</contact_name>
        <contact_address>Ethics Committee of Bandar Abbas University of Medical Sciences,Research Deputy Building, Shahid Mohammadi Hospital, Jomhoori Islami Blvd. Bandar Abbas Hormozgan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
